Long-Term Efficacy and Safety of Ablative Single-Fraction Stereotactic MR-Guided Adaptive Radiotherapy from the Multi-Center Phase 2 SMART ONE Trial Conference

Chuong, MD, Mittauer, KE, Kotecha, R et al. (2026). Long-Term Efficacy and Safety of Ablative Single-Fraction Stereotactic MR-Guided Adaptive Radiotherapy from the Multi-Center Phase 2 SMART ONE Trial . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 126(1), e325-e325.

cited authors

  • Chuong, MD; Mittauer, KE; Kotecha, R; Glide-Hurst, C; Demissie, S; Kalman, NS; Tom, MC; Crosby, J; Tolakanahalli, RP; Gutierrez, A; Bassiri, N; Mehta, MP; Bassetti, MF

authors

date/time interval

  • September 26, 2026 -

publication date

  • September 1, 2026

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology

Location

  • MA, Boston

Conference

  • 68th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO)

publisher

  • ELSEVIER SCIENCE INC

start page

  • e325

end page

  • e325

volume

  • 126

issue

  • 1